Table 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

Table 4_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

Image 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

Image 5_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

Table 1_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

Image 6_PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-an... حسب Chao Song (379006)

"…Background<p>Combining PD-1/PD-L1 inhibitors with chemotherapy (PIC) is a standard first-line treatment for advanced non-small cell lung cancer (NSCLC). The addition of bevacizumab to this regimen (PD-1/PD-L1 inhibitors+bevacizumab+chemotherapy [PIBC]) remains controversial regarding its potential to enhance antitumor efficacy in clinical practice. …"

SUMO-dependent disruption of SET-26 complex formation. حسب Cátia A. Carvalho (20513858)

Average kidney and heart weight of rats. حسب Diana Bylan (20421873)

"…To date, there are no treatments to reverse kidney fibrosis. Cannabis is an aromatic herb that is widely known for its anti-diabetic and anti-inflammatory properties. …"

The relationship between the number of publications and taxa richness in Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

Georeferenced faunistic occurrence records reported from Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

Assessment of inventory completeness in five of the most studied taxa from Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000, Stratified by age groups in Adults in the United States, 1999 to 2020. حسب Aman Goyal (19231397)

الموضوعات:

Dynamics of the scientific publications regarding the fauna of Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

Association of BMI with primary and secondary outcomes after adjusting for age, sex, index of multiple deprivation (for the United Kingdom data), primary surgical indication and Am... حسب Epaminondas Markos Valsamis (8194083)

الموضوعات:

Animal species richness reported from Retezat National Park (RNP), according to the scientific literature and GBIF. حسب Dan Cogălniceanu (479439)

الموضوعات:

Spatial bias in faunistic surveys in Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

BMI distribution of study population using World Health Organisation (WHO) categories. حسب Epaminondas Markos Valsamis (8194083)

الموضوعات:

The cumulative number of species occurrences according to altitude in Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات:

(A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 t... حسب Aman Goyal (19231397)

الموضوعات:

Species richness of Syrphidae (order Diptera) from Retezat National Park. حسب Dan Cogălniceanu (479439)

الموضوعات: